Datavault AI Inc. provides data monetization, credentialing, digital engagement and real-world asset tokenization technologies through a cloud-based platform spanning Acoustic Sciences and Data Sciences. Its recurring announcements describe AI-driven data experiences, asset valuation and monetization, Information Data Exchange® capabilities for Digital Twins and name, image and likeness licensing, and patented audio technologies including WiSA, ADIO and Sumerian.
Company news also covers registered equity offerings, use of proceeds for a quantum-ready GPU edge network, financial-results communications, and material agreements tied to tokenized assets and exchange technology. Updates often connect Datavault AI's common stock capital structure with product deployment, licensing, analytics, marketing automation and industry applications in sports and entertainment, education, fintech, healthcare, energy and other markets.
DataMeds AI (NASDAQ:MEDS) announced that subsidiary Helomics received Humana Medicaid coverage for its ChemoFx chemotherapy-response assay in gynecologic cancers. The policy became effective July 22, 2026. ChemoFx tests a patient's live tumor cells to help inform chemotherapy selection and is billed under CPT codes 81535 and 81536.
Members may be eligible for testing during initial biopsy or surgery, for recurrent or treatment-refractory cancer, when recommended treatment cannot be tolerated, or for rare cancers without established treatment guidelines. Coverage does not extend to all Humana plans. Helomics previously invested in laboratory automation. DataMeds said the laboratory is positioned to support additional volume as coverage grows and is preparing data for publication to support label expansion. ChemoFx is a laboratory-developed test without FDA clearance or approval.
Datavault AI (DVLT) will participate in the 2026 Maxim Growth Summit, taking place October 12–14 at The Hard Rock Hotel NYC.
Brett Moyer, chairman and chief financial officer, will meet institutional investors in one-on-one sessions and engage with senior Maxim research analysts on October 13, 2026. Portions of the summit will also be streamed online.
Datavault AI (DVLT) appointed Christopher R. Hardt as an independent director, effective October 3, 2026, following its acquisition of NYIAX. NYIAX designated Hardt in connection with the completed acquisition; he previously served on its board. He will also serve on Datavault AI's Audit Committee and Nominating and Corporate Governance Committee.
The August 2026 acquisition added patented exchange technology and contract management capabilities to Datavault AI's platform. Hardt brings more than 30 years of global financial leadership experience. His career includes partnership roles at PricewaterhouseCoopers, serving as chief financial officer of Abri Capital and board positions at NYIAX and Collective Audience. At PwC, he led Consumer Markets SEC Services in New York, advising companies on SEC filings and regulatory matters.
DataMeds AI (MEDS) filed doing-business-as names DataMEDS SI and Corexa Health SI and confirmed completion of its Dream Bowl token distribution.
The distribution was paid on September 9, 2026 to qualifying holders of record at the close of business on August 7, 2026. Entitlement is 50 tokens per common share, including shares issuable or deemed issuable from eligible securities. The tokens were listed on Biconomy in the third quarter of 2026. Receiving them requires a Datavault AI (DVLT) digital wallet and an Opt-In Agreement. The tokens are personal-use digital collectibles, confer no equity or monetary-payment rights, and may not have or maintain any value.
Datavault AI (DVLT) CEO Nathaniel T. Bradley will present “Operating System for Tokenized Assets” at XRP Seoul on October 3, 2026.
The session is scheduled for 3:05 p.m. KST at the Grand Hyatt Seoul, South Korea. Bradley will discuss valuation, credentialing and verified metadata for real-world asset tokenization, including the company's DataValue, DataScore and Information Data Exchange technologies. He will also join “How Traditional Finance Is Embracing Tokenization” at 5:40 p.m. KST.
Datavault AI will exhibit and demonstrate its ADIO acoustic data transmission technology at its booth and from the keynote stage. It will distribute a commemorative digital collectible minted on the XRP Ledger to attendees, available through the ADIO web app after Bradley's keynote.
DataMeds AI (MEDS) reported that Corexa Pharmacy recorded preliminary, unaudited September 2026 revenue of more than $1 million. Revenue increased more than 66 percent from July 2026. Corexa Pharmacy is a division of wholly owned subsidiary Corexa Health, and its rebranding was completed in the first month of the third quarter.
The recently launched Health Lives Here mobile application offers Corexa Pharmacy as a fulfillment option for telehealth prescriptions. DataMeds AI has also closed the Helomics Corporation acquisition, which the company believes opens potential demand for oncology medications and nutritional support products. An upgrade of Corexa Pharmacy's physical location is underway to make it the flagship model for the Health Lives Here initiative with NFL Alumni Health.
DataMeds AI (MEDS) and Tollo Health launched the Health Lives Here app, initially focused on people using GLP-1 medications.
The app offers telehealth consultations, access to cash-pay branded GLP-1 medicines through DataMeds subsidiary Corexa Health’s pharmacy, Tollo Health nutrition products, wearable-data tracking and an AI health coach. NFL Alumni Health is helping market it. A national network is being established from Corexa’s 6,500+ independent-pharmacy network; Moose Pharmacy of Concord is the first participating store.
The companies intend to add patients with Long COVID in fourth-quarter 2026, followed by cancer patients. Direct-to-consumer lab tests are planned soon where permitted by law. DataMeds plans a digital-twin option—a virtual patient model—and a provider network for 2027.
DataMeds AI (MEDS) announced that interim Co-CEO Gerald Commissiong will present at the National Telehealth and Virtual Care Summit on September 28.
His “What Patients Really Want” session is scheduled for 9:15 a.m. PT in Las Vegas. He will discuss patient ownership of health data and the company’s Health Lives Here campaign and mobile healthcare application with NFL Alumni Health.
Datavault AI (DVLT) plans a rights offering for holders of its common stock and certain other eligible securities, with an October 9, 2026 record date.
Each holder will receive one transferable subscription right for a Common Unit per common share and one subscription right for a Preferred Unit per 100 common shares. Common Units, priced at $0.20, comprise one common share plus Series A and Series B rights to buy additional common shares at $0.25 and $0.30, expiring six and twelve months after closing, respectively. The company expects to offer up to $50 million of Common Unit rights.
Preferred Units, priced at $25.00, include one preferred share plus Series 1 and Series 2 rights to buy more preferred at $30.00 and $35.00, also expiring six and twelve months after closing. Up to 3,000,000 Preferred Units, or $75 million of rights, are expected. The preferred carries a $25 liquidation preference and a cumulative dividend of $2.10 per year, ranks senior to common, and is not convertible.
Datavault AI (DVLT) and Cutting-Edge Sports Management announced Dream Bowl XV, the 15th edition of the college football all-star game, scheduled for Sunday, January 17, 2027, at AT&T Stadium in Arlington, Texas, with a planned national ESPN broadcast.
Dream Bowl XV extends Datavault AI’s role as intellectual property licensing partner and sponsor, and introduces a new Bowl Combine that can award two eligible student-athletes roster spots and playing time based solely on performance. Datavault AI will operate the combine through its Event Citadel™ registration business and deploy VerifyU™, ADIO®, DataScore®, DataValue®, Information Data Exchange® and NIL Vault™ technologies to credential athletes and record combine results. The four-day weekend will feature practices, scouting sessions, the combine and the game, with detailed ticketing and eligibility information to be posted on dreambowl.net.